ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

β-defensin-3 promoted osteosarcoma progression via activating the PI3K/AKT pathway and regulated tumor immune response.

Kang Zou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.